Epigenetic silencing has been also demonstrated in T-cell acute lymphoblastic leukemia (T-ALL), where KLF4 serves as tumor suppressor in experimental animal models and xenografts generated using lymphoblasts from pediatric T-ALL patients (Shen et al., 2017; Chen et al., 2021). The gene discussed is KLF4; the disease is neoplasm.